UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Annals of oncology, 2020-06, Vol.31 (6), p.724-744

2020

Volltextzugriff (PDF)

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Beilstein journal of organic chemistry, 2021-09, Vol.17 (1), p.2417-2424

2021

Volltextzugriff (PDF)

Protective Coatings Based on Titanium Diboride and Carbon Fillers

Protection of metals and physical chemistry of surfaces, 2023-08, Vol.59 (4), p.638-647

2023

Volltextzugriff (PDF)

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Metal science and heat treatment, 2021-11, Vol.63 (7-8), p.363-368

2021

Volltextzugriff (PDF)

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Glass and ceramics, 2018-01, Vol.74 (9-10), p.372-377

2018

Volltextzugriff (PDF)

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Clinical pharmacology: advances and applications, 2022-01, Vol.14, p.69-90

2022

Volltextzugriff (PDF)

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Glass and ceramics, 2016-07, Vol.73 (3-4), p.77-81

2016

Volltextzugriff (PDF)

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Annals of oncology, 2018-10, Vol.29, p.viii442-viii442

2018

Volltextzugriff (PDF)

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

European journal of cancer (1990), 2015-09, Vol.51, p.S674-S674

2015

Volltextzugriff (PDF)

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S679-S679

2015

Volltextzugriff (PDF)

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S326-S327

2014

Volltextzugriff (PDF)

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

EUROPEAN JOURNAL OF CANCER, 2017, Vol.72, p.S122-S123

2017

Volltextzugriff (PDF)

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

Russian journal of non-ferrous metals, 2019-07, Vol.60 (4), p.348-353

2019

Volltextzugriff (PDF)

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

European journal of cancer (1990), 2015-09, Vol.51, p.S676-S676

2015

Volltextzugriff (PDF)

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S72-S72

2015

Volltextzugriff (PDF)

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

European journal of cancer (1990), 2015-09, Vol.51, p.S722-S722

2015

Volltextzugriff (PDF)

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S271-S271

2013

Volltextzugriff (PDF)

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

Glass physics and chemistry, 2022-10, Vol.48 (5), p.400-402

2022

Volltextzugriff (PDF)

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

European journal of cancer (1990), 2012-11, Vol.48, p.83-83

2012

Volltextzugriff (PDF)

Distribution of chloride ions along the flight path of aircraft (Overview)

Journal of physics. Conference series, 2022-12, Vol.2373 (2), p.22008

2022

Volltextzugriff (PDF)

1444 POSTER Evaluation of Hand-foot Syndrome (HFS) as a Potential Biomarker of Sunitinib (SU) Efficacy in Patients (pts) With Metastatic Renal Cell Carcinoma (mRCC) and Gastrointestinal Stromal Tumour (GIST)

European journal of cancer (1990), 2011, Vol.47, p.S182-S182

2011

Volltextzugriff (PDF)

Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3093-3093

2011

Volltextzugriff (PDF)

P2.11A.13 Cytokine Release Syndrome from Dual Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: FAERS Analysis

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S257-S258

2024

Volltextzugriff (PDF)

9306 ORAL Safety and Efficacy of Ipilimumab-treated Patients With Melanoma and Brain Metastases

European journal of cancer (1990), 2011, Vol.47, p.S654-S654

2011

Volltextzugriff (PDF)

1018P Characterization of liver function tests following tebentafusp in phase III randomized trial comparing tebentafusp with investigator’s choice in first line metastatic uveal melanoma (mUM)

Annals of oncology, 2021-09, Vol.32, p.S856-S857

2021

Volltextzugriff (PDF)

1 – 25 von 904

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(749)
Mit Volltextzugriff
(677)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(113)
Annals Of Oncology
(36)
Journal For Immunotherapy Of Cancer
(32)
Journal Of Translational Medicine
(32)
Cancer Research
(21)
Semiconductors
(17)
Atomic Energy
(13)
European Journal Of Cancer
(13)
Telecommunications & Radio Engineering
(12)
Problemy Tuberkuleza
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Protective Coatings Based on Titanium Diboride and Carbon Fillers

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

Distribution of chloride ions along the flight path of aircraft (Overview)

1444 POSTER Evaluation of Hand-foot Syndrome (HFS) as a Potential Biomarker of Sunitinib (SU) Efficacy in Patients (pts) With Metastatic Renal Cell Carcinoma (mRCC) and Gastrointestinal Stromal Tumour (GIST)

Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit

P2.11A.13 Cytokine Release Syndrome from Dual Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: FAERS Analysis

9306 ORAL Safety and Efficacy of Ipilimumab-treated Patients With Melanoma and Brain Metastases

1018P Characterization of liver function tests following tebentafusp in phase III randomized trial comparing tebentafusp with investigator’s choice in first line metastatic uveal melanoma (mUM)

Aktive Filter

Suchergebnisse filtern